Study to find how effective and safe are different dosages of iron supplements among women with Iron deficiency anaemia.

Randomized controlled trial to evaluate the efficacy and safety of Oral Iron regimens differing in frequency among anaemic women of Coastal Karnataka. - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/081855

Enrollment

Registered

2025-03-06

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

Intervention1: Iron and folic acid tablets on daily and alternate day regimens: â?¢ Participants will receive oral iron supplements (60 mg elemental iron) according to their assigned regimen for 12 we

Eligibility

Inclusion criteria

Inclusion criteria: All women aged 18-49 years with haemoglobin levels less than 12 g/dl.

Exclusion criteria

Exclusion criteria: regnant women, Hb less than 8 g/dl, Sickle cell anaemia, thalassaemia and other haemoglobinopathies

Design outcomes

Primary

Measure	Time frame
Change in heamoglobin levels from baseline and day 84.Timepoint: At baseline and on day 84 after the start of intervention.	—

Secondary

Measure	Time frame
Change in serum ferritin levels, incidence of gastrointestinal symptoms, & compliance.Timepoint: At baseline, 28 days, 56 days &and 84 days from start of intervention	—

Countries

India

Contacts

Public ContactDr Amit Kumar Rao

K S Hegde Medical Academy

dramit.kumar@nitte.edu.in9739864337

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026